Therapeutic area intelligence for Melatonin Receptor Agonist with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 1

Companies

Micro Labs →

Assets

Ramelteon →

Recent signals(3)

RegulatoryJuly 26, 2026

FDA Grants AP Status for Ramelteon ANDA 215243 by Micro Labs

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Ramelteon submitted by Micro Labs.

RegulatoryJuly 3, 2026

FDA Accepts Supplement Application for Ramelteon by Micro Labs

The FDA has accepted a supplemental application for Ramelteon submitted by Micro Labs.

Strategy

June 30, 2026

FDA Grants Approval for Ramelteon ANDA215485 by Hibrow Healthcare

The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 215485 for Ramelteon submitted by Hibrow Healthcare.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Sleep Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.